In this issue:
Deferiprone in PD
Comparison of device-aided therapies on QOL and ‘off’ time in advanced PD
Safinamide added to levodopa in PD with motor fluctuations
Continuous subcutaneous foslevodopa-foscarbidopa in advanced PD
Simvastatin not useful as a disease-modifying treatment for PD
Six action steps to address global disparities in PD
Effect of age and PD duration on efficacy of STN-DBS
Multimodal striatal neuromarkers for distinguishing MSA-P from idiopathic PD
Effects of exercise on depressive symptoms in PD
Please login below to download this issue (PDF)